Combined MRI/ultrasound Efficient For High-risk Prostate Cancer Detection

Combined MRI/ultrasound Efficient For High-risk Prostate Cancer Detection
shutterstock_47436067In a recent study entitled “Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer” researchers showed that by combining target magnetic resonance imaging (MRI) with ultrasound fusion biopsy, they can increase the efficiency of high-risk prostate cancer detection. The study was published in The Journal of the American Association (JAMA). Currently, prostate cancer diagnosis is performed by a standard biopsy, technically denominated as standard extended-sextant biopsy, where a random sample of the prostate is extracted for analysis. However, innovative techniques are emerging with the potential to enhance the efficiency of prostate cancer diagnosis, notably in those patients considered to be at high risk. One such techniques is the combination of targeted magnetic resonance (MR) with ultrasound fusion biopsy, characterized by the stacking of multiparametric magnetic resonance imaging (MP-MRI) in real time with a subsequent targeted biopsy of the areas revealed suspicious in the MP-MRI images. In this study, the authors compared the efficiency of diagnosis in intermediate- to high-risk prostate cancer patients using both targe
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *